Literature DB >> 11023985

The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments.

P Janosch1, A Kieser, M Eulitz, J Lovric, G Sauer, M Reichert, F Gounari, D Büscher, M Baccarini, H Mischak, W Kolch.   

Abstract

Using immobilized GST-Raf-1 as bait, we have isolated the intermediate filament protein vimentin as a Raf-1-associated protein. Vimentin coimmunoprecipitated and colocalized with Raf-1 in fibroblasts. Vimentin was not a Raf-1 substrate, but was phosphorylated by Raf-1-associated vimentin kinases. We provide evidence for at least two Raf-1-associated vimentin kinases and identified one as casein kinase 2. They are regulated by Raf-1, since the activation status of Raf-1 correlated with the phosphorylation of vimentin. Vimentin phosphorylation by Raf-1 preparations interfered with its polymerization in vitro. A subset of tryptic vimentin phosphopeptides induced by Raf-1 in vitro matched the vimentin phosphopeptides isolated from v-raf-transfected cells labeled with orthophosphoric acid, indicating that Raf-1 also induces vimentin phosphorylation in intact cells. In NIH 3T3 fibroblasts, the selective activation of an estrogen-regulated Raf-1 mutant induced a rearrangement and depolymerization of the reticular vimentin scaffold similar to the changes elicited by serum treatment. The rearrangement of the vimentin network occurred independently of the MEK/ERK pathway. These data identify a new branch point in Raf-1 signaling, which links Raf-1 to changes in the cytoskeletal architecture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023985     DOI: 10.1096/fj.99-0883com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

Review 2.  Introducing intermediate filaments: from discovery to disease.

Authors:  John E Eriksson; Thomas Dechat; Boris Grin; Brian Helfand; Melissa Mendez; Hanna-Mari Pallari; Robert D Goldman
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

3.  DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.

Authors:  Hui Cong; Ru-Yong Yao; Zhen-Qing Sun; Wen-Sheng Qiu; Ya-Sai Yao; Tong-Tong Feng; Chao Xin; Jun Liang; L U Yue
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

4.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells.

Authors:  Wells S Brown; Jahan S Khalili; Tania G Rodriguez-Cruz; Greg Lizee; Bradley W McIntyre
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

6.  Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Authors:  Guy Lahat; Quan-Sheng Zhu; Kai-Lieh Huang; Suizhao Wang; Svetlana Bolshakov; Jeffery Liu; Keila Torres; Robert R Langley; Alexander J Lazar; Mien Chie Hung; Dina Lev
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

7.  B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells.

Authors:  Juan J Bonfiglio; Carolina Inda; Sergio Senin; Giuseppina Maccarrone; Damián Refojo; Damiana Giacomini; Christoph W Turck; Florian Holsboer; Eduardo Arzt; Susana Silberstein
Journal:  Mol Endocrinol       Date:  2013-01-31

Review 8.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22

9.  Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells.

Authors:  Arun Kanakkanthara; Pisana Rawson; Peter T Northcote; John H Miller
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

10.  Increased expression of desmin and vimentin reduces bladder smooth muscle contractility via JNK2.

Authors:  Elham Javed; Chellappagounder Thangavel; Nagat Frara; Jagmohan Singh; Ipsita Mohanty; Joseph Hypolite; Ruth Birbe; Alan S Braverman; Robert B Den; Satish Rattan; Stephen A Zderic; Deepak A Deshpande; Raymond B Penn; Michael R Ruggieri; Samuel Chacko; Ettickan Boopathi
Journal:  FASEB J       Date:  2019-12-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.